Shares of Johnson & Johnson advanced 1.08% to $164.27 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.82% to 4,646.71 and Dow Jones Industrial Average falling 0.66% to 36,079.94. The stock’s rise snapped a five-day losing streak. Johnson & Johnson closed $15.65 below its 52-week high ($179.92), which the company achieved on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert. fell 0.72% to $401.34, Merck & Co. Inc. rose 1.56% to $84.01, and Pfizer Inc. rose 3.64% to $49.02. Trading volume (6.2 M) remained 119,505 below its 50-day average volume of 6.3 M.